Event Calendar

Oncology Research

Download Breakout Session Overviews   | Download Schedule of Breakout Sessions   | View Preconference Workshops   | View Conference Schedule

2019 Agenda

Friday, September 27, 1:15 to 2:00                                       

Oncology Investigator Initiated Clinical Trial Protocols: A Comprehensive Review of Eligibility Criteria and Study Procedures

A clinical trial protocol provides details regarding design, recruitment, treatment plan, regulatory requirements and logistics of a study.  Ms. Mukit will go deeper into two specific sections of the protocol: 'eligibility criteria’ and ‘study procedures’. This presentation will be a beginners level presentation based on oncology investigator initiated interventional clinical trials. Ms. Mukit will focus on the specifics of some universal eligibility criteria and how they can be presented effectively. She will also shed light on the most commonly used study procedures and cover the vital specifics that need to be stated with each study procedure. The impact of these two sections on the ‘Recruitment and Retention’ capacity of a clinical trial will also be discussed. 109

Presenter: Sabeeha Mukit, MBBS, MS, Medical Writer, Northwestern University

Sabeeha Mukit, MBBS, MS, Medical Writer,

Northwestern University

Track: Oncology Research

Friday, September 27, 2:05 to 2:50                                  

Intratumoral Injection Trials: IR Experience

Injecting cancer treatments have shown promise in clinical trials, whether through vaccines or direct intratumoral injections. This presentation is an overview of the management and coordination of intratumoral injection trials wherein procedures were performed by faculty members of the Interventional Radiology Department of MD Anderson Cancer Center. In the past couple of years, the IR Department has been challenged with the growing demands of Phase I and Phase II intratumoral injection trials, which were primarily driven by different departments such as Investigational Cancer Therapeutics/Phase I, Melanoma, Sarcoma and others.  111

Presenter: Maria Briones, MD, CCRP, Clinical Research Team Lead, Interventional Radiology, UT MD Anderson Cancer Center

Track: Oncology Research 

Friday, September 27, 3:25 to 4:10                                                       

Putting Everything in Perspective: What You Need to Know to Survive in Clinical Trial Management

Ms. Stewart will discuss information from the data management side and regulatory side of managing clinical trials. Ways to navigate requests from sponsors/CROs will also be presented. 113

Presenter: Diandra Stewart, BS, CCRP, Clinical Research Associate, Cancer Centers of SW Oklahoma

Track: Oncology Research

Friday, September 27, 4:15 to 5:00                                       

Complementary and Alternative Medicine Pros and Cons 

Nowadays an increasing number of patients from various age groups are moving to integrative medicine (IM). IM is a coordinated approach that uses Complementary and Alternative Medicine (CAM), and conventional therapies. Patients may not discuss its use with their healthcare providers. These therapies may enhance or interfere with traditional cancer treatments. Healthcare providers should focus on strategies for effective communication with patients to discuss the use of CAM and notify about risks and benefits associated with it. 115

Presenter: Rashmi Pande, BDS, MS, CCRP, Drug Safety Scientist

 Track: Oncology Research